GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 744 filers reported holding GLAXOSMITHKLINE PLC in Q3 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $30,000 | 0.0% | 700 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $30,000 | -3.2% | 700 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $31,000 | +14.8% | 700 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $27,000 | -38.6% | 700 | -36.4% | 0.00% | 0.0% |
| Q2 2021 | $44,000 | +12.8% | 1,100 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $39,000 | -2.5% | 1,100 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $40,000 | -2.4% | 1,100 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $41,000 | -8.9% | 1,100 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $45,000 | -78.9% | 1,100 | -80.4% | 0.00% | -77.8% |
| Q1 2020 | $213,000 | +0.9% | 5,600 | +24.4% | 0.01% | +12.5% |
| Q4 2019 | $211,000 | -45.1% | 4,500 | -50.0% | 0.01% | -50.0% |
| Q3 2019 | $384,000 | +6.7% | 9,000 | 0.0% | 0.02% | +6.7% |
| Q2 2019 | $360,000 | -4.3% | 9,000 | 0.0% | 0.02% | -6.2% |
| Q1 2019 | $376,000 | -21.3% | 9,000 | -28.0% | 0.02% | -20.0% |
| Q4 2018 | $478,000 | -5.0% | 12,500 | 0.0% | 0.02% | +11.1% |
| Q3 2018 | $503,000 | -22.0% | 12,500 | -21.9% | 0.02% | -25.0% |
| Q2 2018 | $645,000 | +3.2% | 16,000 | 0.0% | 0.02% | +4.3% |
| Q1 2018 | $625,000 | -2.0% | 16,000 | -11.1% | 0.02% | +109.1% |
| Q4 2017 | $638,000 | +74.8% | 18,000 | +100.0% | 0.01% | -15.4% |
| Q3 2017 | $365,000 | -6.9% | 9,000 | -0.9% | 0.01% | -7.1% |
| Q2 2017 | $392,000 | +2.6% | 9,083 | 0.0% | 0.01% | +7.7% |
| Q1 2017 | $382,000 | -83.5% | 9,083 | -84.9% | 0.01% | -80.9% |
| Q4 2016 | $2,314,000 | +5.0% | 60,083 | +17.6% | 0.07% | +6.2% |
| Q3 2016 | $2,204,000 | -4.2% | 51,083 | -3.8% | 0.06% | -4.5% |
| Q2 2016 | $2,301,000 | +4.7% | 53,083 | -2.1% | 0.07% | 0.0% |
| Q1 2016 | $2,197,000 | +625.1% | 54,197 | +624.4% | 0.07% | +570.0% |
| Q4 2015 | $303,000 | +0.3% | 7,482 | -5.1% | 0.01% | -16.7% |
| Q3 2015 | $302,000 | +44.5% | 7,882 | +57.3% | 0.01% | +50.0% |
| Q2 2015 | $209,000 | -3.7% | 5,010 | +6.9% | 0.01% | 0.0% |
| Q1 2015 | $217,000 | +35.6% | 4,685 | +56.2% | 0.01% | +14.3% |
| Q4 2013 | $160,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |